Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 60, Issue 10, Pages 2963-2975Publisher
SPRINGER
DOI: 10.1007/s10620-015-3698-5
Keywords
Inflammatory bowel disease; Animal models; Dopamine; D2 dopamine receptor; Vascular permeability
Categories
Funding
- Department of Veterans Affairs, Veterans Health Administration Merit Review Grant [VAMR0710-580, VAMR0810-877]
- U.S. Civilian Research & Development Foundation (CRDF) CREST II Junior Scientist Research Collaboration Program [09DP036-05]
- Ministry of Education and Science of Ukraine [15BF036-01]
Ask authors/readers for more resources
VEGF-induced vascular permeability and blood vessels remodeling are key features of inflammatory bowel disease (IBD) pathogenesis. Dopamine through D2 receptor (D2R) inhibits VEGF/VPF-mediated vascular permeability and angiogenesis in tumor models. In this study, we tested the hypothesis that pathogenesis of IBD is characterized by the disturbance of dopaminergic system and D2R activity. IL-10 knockout (KO) mice and rats with iodoacetamide-induced ulcerative colitis (UC) were treated intragastrically with D2R agonists quinpirole (1 mg/100 g) or cabergoline (1 or 5 A mu g/100 g). Macroscopic, histologic, and clinical features of IBD, colonic vascular permeability, and angiogenesis were examined. Although colonic D2R protein increased, levels of tyrosine hydroxylase and dopamine transporter DAT decreased in both models of IBD. Treatment with quinpirole decreased the size of colonic lesions in rats with iodoacetamide-induced UC (p < 0.01) and reduced colon wet weight in IL-10 KO mice (p < 0.05). Quinpirole decreased colonic vascular permeability (p < 0.001) via downregulation of c-Src and Akt phosphorylation. Cabergoline (5 A mu g/100 g) reduced vascular permeability but did not affect angiogenesis and improved signs of iodoacetamide-induced UC in rats (p < 0.05). Treatment with D2R agonists decreased the severity of UC in two animal models, in part, by attenuation of enhanced vascular permeability and prevention of excessive vascular leakage. Hence, the impairment dopaminergic system seems to be a feature of IBD pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available